Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

A decade ago research into the fundamental mechanisms of cell death: apoptosis, necroptosis, pyroptosis, ferroptosis, and emerging forms of programmed cell survival was rapidly expanding. To support ...

Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell ...

Melissa Lambarena is a senior writer on the credit cards team at NerdWallet. She has enthusiastically covered credit card-related topics for over nine years. Her prior experience includes nine years ...